Novo Holdings acquired a 24.9% equity stake in Envirotainer, a Stockholm, Sweden-based provider of temperature controlled airfreight solutions for the pharmaceutical supply chain.
Novo Holdings has agreed to acquire the stake in Envirotainer in partnership with the private equity firm Cinven.
The company intends to use the proceeds from the investment to develop its technology and expand its container fleet and global service network.
Led by Michael Berg, CEO, Envirotainer designs, manufactures and leases active temperature controlled containers used primarily for air freighting biopharma products, transporting up to two million doses of medicine per day.
The group serves c. 600 customers worldwide, including many of the blue-chip global biopharma companies operating from regional centers in Stockholm, Frankfurt, Dallas and Singapore, with a portfolio of more than 5,800 leased containers globally.